Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Neurobiology of Disease|February 12, 2026
Distinct neuronal mechanisms for motor impairment and seizures in a novel mouse model of SCN8A epileptic encephalopathyMidhun N K Anne, Laura Kakuk-Atkins, Jason Kaplan, et al.
Oncotarget|January 7, 2017
Synthetic high-density lipoproteins as targeted monotherapy for chronic lymphocytic leukemiaKaylin M McMahon, Cristina Scielzo, Nicholas L Angeloni, et al.
Oncotarget|September 3, 2016
Concordance between genomic alterations assessed by next-generation sequencing in tumor tissue or circulating cell-free DNAYoung Kwang Chae, Andrew A Davis, Benedito A Carneiro, et al.
European Journal of Cancer (Oxford, England : 1990)|August 17, 2025
Enfortumab vedotin in patients with advanced non-small cell lung cancer after disease progression on platinum- and PD-1/PD-L1 inhibitor-containing regimens: Phase 2 international multicenter EV-202 studyKei Muro, Trevor Feinstein, Joaquina Baranda, et al.
Blood Advances|September 27, 2023
Ibrutinib maintenance after frontline treatment in patients with mantle cell lymphomaReem Karmali, Jeremy S Abramson, Deborah M Stephens, et al.
Haematologica|October 13, 2022
A phase Ib trial of mivavotinib (TAK-659), a dual SYK/FLT3 inhibitor, in patients with relapsed/refractory acute myeloid leukemiaKeith W Pratz, Jason Kaplan, Moshe Levy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 5, 2026
Enfortumab vedotin plus pembrolizumab as first-line treatment in recurrent or metastatic head and neck squamous cell carcinoma: results from EV-202 cohort 9Paul L Swiecicki, Glenn J Hanna, Jessica L Geiger, et al.
Ejhaem|July 18, 2022
Phase Ib study of combinations of avadomide (CC-122), CC-223, CC-292, and rituximab in patients with relapsed/refractory diffuse large B-cell lymphomaVincent Ribrag, Julio C Chavez, Carola Boccomini, et al.
British Journal of Haematology|May 3, 2019
Multicentre retrospective study of intravascular large B-cell lymphoma treated at academic institutions within the United StatesMarcus Geer, Emily Roberts, Maryann Shango, et al.
Pageof 3